Savvy Updates 6/12/23: NovoNordisk Acquires BioCorp, Go Bionic Interview with Stacey Simms, Alexander Zverev Can’t Inject Insulin on Tennis Court, Hyperglycemia, Metformin & Long Covid, KnowLabs Gen1 Prototype, Residual Insulin, Insect-inspired Microphones, Non-Invasive CGMs Just a Dream?

Savvy Updates 6/12/23: NovoNordisk Acquires BioCorp, Go Bionic Interview with Stacey Simms, Alexander Zverev Can’t Inject Insulin on Tennis Court, Hyperglycemia, Metformin & Long Covid, KnowLabs Gen1 Prototype, Residual Insulin, Insect-inspired Microphones, Non-Invasive CGMs Just a Dream?

Novo Nordisk says in talks to acquire French device-maker Biocorp for $165M by Elise Reuter for MedTechDive.com, 5 June 2023. Novo Nordisk wants to innovate faster and develop new connected devices, and expects that Biocorp would complement its internal efforts, said...
Savvy Updates, 5/15/23: Know Labs Study, TIR & Young T1Ds & Insulins, Insulin Resistance, Capsule Studies Microbiome, Insulin Temp Stability, Watermelon Heart-Healthy, Embecta/Tidepool Partner for T2D, Glucomate, Diabetes Epidemic in UK, Legislation to Fix Prior Auth

Savvy Updates, 5/15/23: Know Labs Study, TIR & Young T1Ds & Insulins, Insulin Resistance, Capsule Studies Microbiome, Insulin Temp Stability, Watermelon Heart-Healthy, Embecta/Tidepool Partner for T2D, Glucomate, Diabetes Epidemic in UK, Legislation to Fix Prior Auth

Know Labs reports data from feasibility study of Bio-RFID sensor reported on MedicalDevice-Network.com, 8 May 2023. Know Labs has reported data from a new technical feasibility study of its Bio-RFID sensor technology for non-invasive glucose monitoring, compared to...
Savvy Updates 5/1/23:  Lilly Sells Off Baqsimi, Humacyte Biovascular Pancreas, Dexcom Growth, Know Labs Non-Invasive Sensor, Medtronic Resolves FDA Warning Letter, Omnipod GO for T2D, Doctors More Neurotic, Diabetes Standards of Care, 2023

Savvy Updates 5/1/23: Lilly Sells Off Baqsimi, Humacyte Biovascular Pancreas, Dexcom Growth, Know Labs Non-Invasive Sensor, Medtronic Resolves FDA Warning Letter, Omnipod GO for T2D, Doctors More Neurotic, Diabetes Standards of Care, 2023

Lilly sells emergency diabetes drug for $500M by Jonathan Gardner for BioPharmaDive.com, 24 April 2023. Eli Lilly will sell its emergency diabetes treatment Baqsimi to Amphastar Pharmaceuticals for $500 million upfront, the company said, divesting a drug launched...
Savvy Updates, 4/3/23: Glucose-run Fuel Cell to Power Insulin Release, Inreda Diabetic AP Coming to Market 2024, Biomea Fusion BMF-219 May Preserve Beta Cells, Bigfoot Biomedical Buys Insulin Titration Algorithm, Verapamil Preserves C-Peptide Levels, OOP Cost of Diabetes Medications, PBMs Under Scrutiny, Splenda® Stevia Farm

Savvy Updates, 4/3/23: Glucose-run Fuel Cell to Power Insulin Release, Inreda Diabetic AP Coming to Market 2024, Biomea Fusion BMF-219 May Preserve Beta Cells, Bigfoot Biomedical Buys Insulin Titration Algorithm, Verapamil Preserves C-Peptide Levels, OOP Cost of Diabetes Medications, PBMs Under Scrutiny, Splenda® Stevia Farm

Scientists use implanted glucose-run fuel cell to power insulin release by Nick Paul Taylor for MedTechDive.com, 29 March 2023.   There is a need for better ways to power medical implants. Devices either have a battery that gradually runs down and...
Skip to content